Left Right

Therapeutic Advances in Drug Safety Publishes DCBA Article on Abuse-Deterrent Formulations

Feb 20, 2015 | | Corporate Governance, Drug policy, Health Law, Law, Legislation, Media, Pharmaceuticals | No Comments

Yesterday, Therapeutic Advances in Drug Safety digitally published Abuse-Deterrent Formulations: Transitioning the Pharmaceutical Market to Improve Public Health and Safety, authored by DCBA Law and Policy’s managing attorney Michael C. Barnes, associate attorney Stacey L. Worthy, and former staff attorney Benjamin Tarbell.

The article evaluates abuse-deterrent formulations (ADFs) as a method to reduce prescription drug abuse while ensuring access to vital medications for individuals with legitimate need; assesses the pros and cons of ADFs and the current state of ADF adoption in the market; and develops policy recommendations to transition the market to ADFs. It also finds that even an incremental reduction in abuse can have a significant impact on the nation by reducing the costly social, physical, mental, and public health problems resulting from abuse. The article argues that federal ADF policy does not reflect the urgency of the prescription drug abuse epidemic and does not go far enough toward changing the status quo. It recommends policies to encourage innovation and a market shift toward ADFs.

Leave a reply